1-12 of 12
Philip T. Murphy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Application of a Novel Artificial Intelligence Algorithm to Understand Spatial Immune Cell Relationships in Newly Diagnosed Multiple Myeloma

Paraic Behan, Sahin Sarihan, Megan Chiasson, Pir Zainulabdeen Jan Sarhandi, Joanna Fay, John P Quinn, Philip T Murphy, Katherine M Sheehan, Siobhan V Glavey
Journal: Blood
Blood (2024) 144 (Supplement 1): 4983.
https://doi.org/10.1182/blood-2024-202564
Published: 2024
Journal Articles

Identification of Drivers of SKY92 High-Risk Multiple Myeloma

Roisin McAvera, Izabela Cymer, Niamh McAuley, Sarah Badar, Grace O'Neill, Philip T Murphy, Quinn John, Siobhan V Glavey
Journal: Blood
Blood (2024) 144 (Supplement 1): 5771.
https://doi.org/10.1182/blood-2024-209762
Published: 2024
Journal Articles

Genome Scale Prediction of Functional Target Networks Uncovers Candidate Vulnerabilities in Sky-92 High Risk Multiple Myeloma

Sahin Sarihan, Roisin McAvera, Catherine Duane, Philip T Murphy, Quinn John, Rowan Kuiper, Ian Overton, Siobhan V Glavey
Journal: Blood
Blood (2024) 144 (Supplement 1): 3347.
https://doi.org/10.1182/blood-2024-209694
Published: 2024
Journal Articles

Acute Abdominal and Pelvic Complications in Patients with Non-Promyelocytic Acute Myeloid Leukaemia Undergoing Intensive Induction Chemotherapy Are Associated with Favorable Prognosis

Philip T Murphy, Mohammed Alsaleh, Harris Cheema, Quinn John, Siobhan Glavey, Jeremy Sargent, Dawn Jennifer Swan
Journal: Blood
Blood (2023) 142 (Supplement 1): 5858.
https://doi.org/10.1182/blood-2023-178204
Published: 2023
Journal Articles

A Phase II Multi-Center Study of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RsqVD) in Newly Diagnosed Multiple Myeloma - Ctrial-IE (ICORG) 13-17 Study

Peter O'Gorman, MD PhD, Michael E O'Dwyer, MD, Oonagh Gilligan, MD, John Quinn, MD PhD, Mark Coyne, MD, Janusz Krawczyk, MD, Philip T Murphy, MD, Lourdes del Rosario McAlester, Orna Harraghy, Orlaith Cormican, Elizabeth Lenihan, Keith Egan, Meegahage Ratnakanthi Perera, MD, Gerard Crotty, Patrick J Hayden, MD, Brian Hennessy, MD MRCPI, FRCPath, Hilary M O'Leary, FRCPath, Kathleen Scott, PhD, Imelda Parker, PhD, Michele Cunnane, Jacinta Marron, Aoife Connell, Elizabeth Coghlan, Jacob P. Laubach, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2016) 128 (22): 2117.
https://doi.org/10.1182/blood.V128.22.2117.2117
Published: 2016
Journal Articles

Strong Correlation Between CTLA-4 and LEF1 Gene Expression Levels in CLL: Targeting of the Wnt/β-Catenin Pathway May Adversely Affect CTLA-4 Expression and Function

Philip T Murphy, MD, Gary Lynch, Stephen Bergin, John Quinn, MD PhD, Siobhan Glavey, MD, Philip W Murphy, Paul Kennedy
Journal: Blood
Blood (2016) 128 (22): 5571.
https://doi.org/10.1182/blood.V128.22.5571.5571
Published: 2016
Journal Articles

Prognostic Significance of WT1 and PRAME Gene Expression in Bone Marrow Samples of MDS and AML Patients Treated with Azacytidine

Claire N Andrews, MB BAO BCh LRCPI SI MRCPI, Karen Murphy, FRCP, FRCPath, Sinead Moran, Patrick Thornton, Nichola Harten, Philip T Murphy, MD MRCPath
Journal: Blood
Blood (2014) 124 (21): 5599.
https://doi.org/10.1182/blood.V124.21.5599.5599
Published: 2014
Journal Articles

Impact Of Dialysis-Dependent Renal Failure At Time Of Myeloma Diagnosis On Overall Survival - a 15-Year Single Centre Analysis

Philip T Murphy, MD, MRCPath, Cherisse Baldeo, MB, Patrick O'Kelly, Jeremy Sargant, MB, Patrick Thornton, MB, Mary McCloy, MB, MRCP, MRCPath, Peter Conlon, MB, Colm Magee, MB, Mark Denton, MB, John Quinn, MB, PhD
Journal: Blood
Blood (2013) 122 (21): 3230.
https://doi.org/10.1182/blood.V122.21.3230.3230
Published: 2013
Journal Articles

Psychometric Performance Of The EORTC Quality-Of-Life Core Questionnaire (QLQ-C30) and QLQ-Multiple Myeloma (QLQ-MY20) In Relapsed/Refractory Multiple Myeloma (RRMM)

Xavier Leleu, MD, PhD, Maria Teresa Petrucci, MD, Manfred Welslau, Isabelle Vande Broek, Philip T Murphy, MD, MRCPath, Andrew Bottomley, PhD, Pamela Bacon, Philip Lewis, PhD, Hélène Gilet, MSc, Benoit Arnould, PhD, Charalampia Kyriakou
Journal: Blood
Blood (2013) 122 (21): 1721.
https://doi.org/10.1182/blood.V122.21.1721.1721
Published: 2013
Journal Articles

Continued Treatment Duration, Drug dosing  and Health-Related Quality Of Life (HRQoL) Of Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving 2 nd and 3 rd Line Treatments: Results From a European Multicentre Study

Maria Teresa Petrucci, MD, Xavier Leleu, MD, PhD, Charalampia Kyriakou, Isabelle Vande Broek, PhD, Philip T Murphy, MD, MRCPath, Philip Lewis, PhD, Pamela Bacon, Benoit Arnould, PhD, Manfred Welslau
Journal: Blood
Blood (2013) 122 (21): 5368.
https://doi.org/10.1182/blood.V122.21.5368.5368
Published: 2013
Journal Articles

Regulation of B-Cell Chronic Lymphocytic Leukaemia Cell Survival and Migration by the VEGF/SEMA3A Axis.

Philip T Murphy, MD, Brendan p Power, PhD, Patrick D Thornton, MD, Judith H Harmey, PhD
Journal: Blood
Blood (2008) 112 (11): 2083.
https://doi.org/10.1182/blood.V112.11.2083.2083
Published: 2008
Journal Articles

Highly Accurate Rhesus and Kell Blood Group Phenotyping of Autologous Red Cells after Allogeneic Blood Transfusion Using a Simplified Method of Microhematocrit Centrifugation and Automation with the DiaMed Classic ID-Gel Station and Diaclon ’Rh Subgroups+K’ Gel Cards.

Philip T. Murphy, Tom Byrne, Sinead A. Moran
Journal: Blood
Blood (2007) 110 (11): 2905.
https://doi.org/10.1182/blood.V110.11.2905.2905
Published: 2007